GLYCOVAXYN AG has a total of 111 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are DE STAAT DER NEDERLANDEN VERT DOOR DE MINI VAN VWS MINIIE VAN VOLKSGEZONDHEID WELZIJN EN SPORT, PIN PHARMA INC and SERUM INSTITUTE OF INDIA PRIVATE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 14 | |
#2 | Canada | 13 | |
#3 | China | 13 | |
#4 | Republic of Korea | 10 | |
#5 | Singapore | 9 | |
#6 | United States | 8 | |
#7 | Brazil | 7 | |
#8 | Israel | 7 | |
#9 | Argentina | 4 | |
#10 | Australia | 4 | |
#11 | EPO (European Patent Office) | 4 | |
#12 | Japan | 4 | |
#13 | Hong Kong | 3 | |
#14 | Mexico | 3 | |
#15 | South Africa | 3 | |
#16 | Belgium | 2 | |
#17 | Chile | 1 | |
#18 | New Zealand | 1 | |
#19 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Macromolecular chemistry and polymers | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Climate change adaptation technologies | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Fermentation | |
#7 | Enzymes | |
#8 | Polysaccharides | |
#9 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kowarik Michael | 54 |
#2 | Wacker Michael | 51 |
#3 | Wetter Michael | 32 |
#4 | Faridmoayer Amirreza | 19 |
#5 | Fernandez Fabiana | 19 |
#6 | Kemmler Stefan J | 14 |
#7 | Wetter Michael L | 10 |
#8 | Michael Wacker | 10 |
#9 | Kowarik Michael T | 10 |
#10 | Gambillara Veronica | 10 |
Publication | Filing date | Title |
---|---|---|
CN107614679A | Composition and method for protein glycosylation | |
WO2016020499A2 | Modified host cells and hybrid oligosaccharides for use in bioconjugate production | |
WO2015124769A1 | Novel polysaccharide and uses thereof | |
WO2015158403A1 | Modified host cells and uses thereof | |
CA2889767A1 | Production of recombinant vaccine in e. coli by enzymatic conjugation | |
CN104902931A | Bioconjugates comprising modified antigens and uses thereof | |
CA2847621A1 | Bioconjugate vaccines made in prokaryotic cells |